Related Experiment Video
Updated: Jan 24, 2026

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine
M R Carvalho1,2,3, D Barata4, L M Teixeira5
13B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
Abstract:
Awareness that traditional two-dimensional (2D) in vitro and nonrepresentative animal models may not completely emulate the 3D hierarchical complexity of tissues and organs is on the rise. Therefore, posterior translation into successful clinical application is compromised. To address this dearth, on-chip biomimetic microenvironments powered by microfluidic technologies are being developed to better capture the complexity of in vivo pathophysiology. Here, we describe a "tumor-on-a-chip" model for assessment of precision nanomedicine delivery on which we validate the efficacy of drug-loaded nanoparticles in a gradient fashion. The model validation was performed by viability studies integrated with live imaging to confirm the dose-response effect of cells exposed to the CMCht/PAMAM nanoparticle gradient. This platform also enables the analysis at the gene expression level, where a down-regulation of all the studied genes (MMP-1, Caspase-3, and Ki-67) was observed. This tumor-on-chip model represents an important development in the use of precision nanomedicine toward personalized treatment.
Insights
Researchers developed a novel tumor-on-a-chip model to test precision nanomedicine delivery. This microfluidic platform accurately assesses nanoparticle drug efficacy, paving the way for personalized cancer treatments.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Traditional 2D in vitro and animal models inadequately represent complex 3D tissue structures, limiting clinical translation.
- Microfluidic 'on-chip' models offer biomimetic microenvironments to better mimic in vivo pathophysiology.
- There is a need for advanced models to evaluate precision nanomedicine efficacy.
Purpose of the Study:
- To develop and validate a "tumor-on-a-chip" model for assessing precision nanomedicine delivery.
- To evaluate the efficacy of drug-loaded nanoparticles using a gradient system.
- To analyze the impact of nanomedicine on gene expression within the tumor model.
Main Methods:
- A microfluidic "tumor-on-a-chip" platform was engineered.
- Drug-loaded nanoparticles (CMCht/PAMAM) were applied in a gradient fashion.
- Cell viability assays with live imaging and gene expression analysis (MMP-1, Caspase-3, Ki-67) were performed for validation.
Main Results:
- The model successfully demonstrated a dose-response effect of nanoparticles on cell viability.
- Live imaging confirmed the efficacy of drug-loaded nanoparticles.
- Gene expression analysis revealed down-regulation of MMP-1, Caspase-3, and Ki-67.
Conclusions:
- The "tumor-on-a-chip" model effectively validates precision nanomedicine delivery.
- This platform supports personalized treatment strategies by assessing nanomedicine efficacy.
- The model represents a significant advancement in preclinical drug development for cancer.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Chromatin Immunoprecipitation- ChIP
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Overview of Microsoft Excel as a Data Analysis Tool
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

